J&J Vision Announces “First of Its Kind” Contact Lenses
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services.
With the clearance from the U.S. Food and Drug Administration, Johnson & Johnson Vision has announced its first of its kind contact lens ACUVUE OASYS® with Transitions® Light Intelligent Technology™ . The new contact lenses give the wearer vision correction as well as a dynamic photochromic filter that works to constantly balance the amount of light that enters the eye. The contact lenses can quickly and smoothly adjust from clear to dark in a change of light conditions and exposure. They feature a blue filtering light and block UV rays.
With its automatic adjusting capabilities, the ACUVUE OASYS® with Transitions® Light Intelligent Technology™ assists the human eye in managing all different types of lighting situations and brightness intensities all day long.
Johnson & Johnson Vision’s partnership with Transitions Optical works to blend the strengths of each company. With ACUVUE®, the Johnson & Johnson brand, as the world leader in contacts, and Transitions Optical as the leading provider of smart adaptive lenses, the companies are coming together to research and develop the very best-in-class innovative vision care.
To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.
Read the original story here.